Skip to content
ppharmaranks
Menu

Best treatments for granuloma inguinale

5 products may treat granuloma inguinale, spanning FDA drug classes such as tetracycline-class drug. The current highest-rated option is doryx mpc. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 5 drugs we list for granuloma inguinale, all are available as lower-cost generics, spanning classes such as tetracycline-class drug. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for granuloma inguinale — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for granuloma inguinale: 1. Doryx Mpc · 2. Doxycycline Hyclate · 3. Doxycycline

Top-rated treatments for granuloma inguinale, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$0View →
270/100$0View →
364/100$0View →
4Not yet rated$0View →
5Not yet rated$0View →

Full ranking · 5 treatments

Frequently asked

What treats granuloma inguinale?
Our catalog lists 5 products that may treat granuloma inguinale, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is doryx mpc.
What is the best-rated treatment for granuloma inguinale?
By our independent recall-safety rating — not an efficacy measure — doryx mpc ranks highest among the products we list for granuloma inguinale. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat granuloma inguinale?
Treatments for granuloma inguinale span FDA drug classes including tetracycline-class drug. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.